SCHEMBL21778650

SCHEMBL21778650

c1ccc(-c2cc(-c3ccc(-c4nc(-c5ccc6ccccc6c5)nc(-c5ccc6ccccc6c5)n4)c4ccccc34)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.53
KMT2A Q03164 8/20 0.53
ALDH1A1 P00352 6/20 0.53
HPGD P15428 6/20 0.53
MAPT P10636 5/20 0.53
CYP1A1 P04798 1/20 0.53
CYP1B1 Q16678 1/20 0.53
NTSR1 P30989 1/20 0.49
KDM4E B2RXH2 4/20 0.47
LMNA P02545 2/20 0.47
GLA P06280 1/20 0.47
CYP1A2 P05177 2/20 0.44
TP53 P04637 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MAOA P21397 2/20 0.43
MAOB P27338 2/20 0.43
ADORA2A P29274 2/20 0.42
ADORA1 P30542 2/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18623321 0.99 MEN1 (0.51) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL18623312 0.96 CYP1A1 (0.51) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL18623304 0.94 CYP1A1 (0.55) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL18623367 0.92 CYP1A1 (0.47) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL18623307 0.91 CYP1A1 (0.55) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25682943 0.91 CYP1A1 (0.55) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL23841438 0.89 MEN1 (0.59) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL18623319 0.88 MEN1 (0.59) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL23633508 0.88 MEN1 (0.49) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL18623309 0.88 MEN1 (0.59) MEN1KMT2AALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580994-B2 Compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10580994-B2 Compound and organic light-emitting device including the same VDAC1, TMEM109, ELOVL1 MEN1 1001/4885KMT2A 2874/4885ALDH1A1 124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.